ARCHIVES

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

This article is from The Cancer Letter archive.

Vol. 12 No. 07 | February 14, 1986

Download PDF Visit The Full Archive

Related Articles

NCI “Month” Appropriate For May, With Several Major Decisions Pending got Start Next 50 Years

May 1, 1987

In Brief: Cavanee Succeeds Coffey As AACR President; Von Hoff Is President-Elect; Awards Presented

April 10, 1998

NCI CTEP-Approved Trials For the Month of September

September 26, 2014

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

NCI Advisory Group, Other Cancer Meetings

March 31, 1989

NCI Clarifies Policy On Small, Short-Term Research Grants

July 5, 1996